FDA approves clinical testing of stem cell-based myopia treatment

02/13/2013 | Pharmaceutical Business Review Online

Advanced Cell Technology's clinical partner, the University of California, Los Angeles, obtained FDA approval for a trial to evaluate the safety of subretinal implantation of human embryonic stem cell-derived cells as a therapy for severe myopia. The study could include 12 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC